Marinomed Biotech AG

Director's Dealing • Jan 27, 2020

Publication Date: 27.01.2020 14:00 EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR)

Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

personal data: responsible party: name: Brigitte EDERER (natural person) ------------------------------------------------------------------------------- reason: reason: responsible party is a person with managerial responsibilities function: Member of an administrative or supervisory board ------------------------------------------------------------------------------- issuer information: name: Marinomed Biotech AG Legal Entity Identifier (LEI): 529900GN3B1EN80XF405 ------------------------------------------------------------------------------- information about deal: ISIN: ATMARINOMED6 description of the financial instrument: Share type: acquisition date: 23.01.2020; UTC+01:00 market: Vienna Stock Exchange AG, XWBO currency: Euro price volume EUR 97 150 shares total volume: 150 shares total price: EUR 14,550 average price: EUR 97 -------------------------------------------------------------------------------- Further inquiry note: Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com

Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at

end of announcement euro adhoc

---

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service